Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer

Written by Regenerative Medicine

This Short Communication by Jingwei Feng et al., University of Tokyo Graduate School of Medicine, Japan, researches the potential of micronized cellular adipose matrix — a bioactive injectable consisting of functional ECM and resident cells such as ASCs — to accelerate healing in ischemic diabetic ulcers.

Poor wound healing in diabetic patients affects millions of patients worldwide. There are many products for wound dressing available, but a transformative therapy is lacking. In a Regenerative Medicine Short Communication by Jingwei Feng et al., from the University of Tokyo Graduate School of Medicine (Japan) a bioactive injectable comprised of functional ECM and resident cells (including ASCs) was developed and investigated as a therapeutic for wound repair of diabetic skin ulcer.

Feng J, Doi K, Kuno S. Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer. Regen. Med. 10(6), 699-708 (2015).